The reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.35BCNY
502.53M · vs all stocks (USD)
Updated Oct 22, 2026
Revenue (TTM)
5.17BCNY
775.29M · vs all stocks (USD)
Updated Oct 22, 2026
Profit Margin
-5.43%
Updated Oct 22, 2026
Beta
0.4490x
vs all stocks
Updated Oct 22, 2026
52-Week Change
16.03%
vs all stocks
Updated Oct 22, 2026
Market Capitalization
3.35BCNY
502.53M · vs all stocks (USD)
Updated Oct 22, 2026
Enterprise Value
4.25BCNY
637.74M · vs all stocks (USD)
Updated Oct 22, 2026
Price to Sales (TTM)
0.6482x
Updated Oct 22, 2026
Price to Book (MRQ)
2.96x
Updated Oct 22, 2026
Enterprise to Revenue
0.8230x
Updated Oct 22, 2026
Enterprise to EBITDA
67.91x
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 34.72×.Updated Oct 22, 2026
Gross Margin
2.48%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives -0.82%.Updated Oct 22, 2026
Profit Margin
-5.43%
Updated Oct 22, 2026
Operating Margin
-0.18%
Updated Oct 22, 2026
Return on Assets (TTM)
-2.17%
Updated Oct 22, 2026
Return on Equity (TTM)
-21.19%
Updated Oct 22, 2026
Revenue (TTM)
5.17BCNY
775.29M · vs all stocks (USD)
Updated Oct 22, 2026
Revenue per Share (TTM)
5.14CNYUpdated Oct 22, 2026
Quarterly Revenue Growth
-0.40%
Updated Oct 22, 2026
Gross Profit (TTM)
-42.51MCNY
-6.37M · vs all stocks (USD)
Updated Oct 22, 2026
EBITDA (TTM)
122.53MCNY
18.37M · vs all stocks (USD)
Updated Oct 22, 2026
Net Income (TTM)
-280.80MCNY
-42.09M · vs all stocks (USD)
Updated Oct 22, 2026
Quarterly Earnings Growth (YoY)
29.20%
Updated Oct 22, 2026
Operating Cash Flow (TTM)
272.03MCNY
40.77M · vs all stocks (USD)
Updated Oct 22, 2026
Levered Free Cash Flow (TTM)
286.79MCNY
42.99M · vs all stocks (USD)
Updated Oct 22, 2026
5-Year Average Dividend Yield
0.56%
vs all stocks
Updated Oct 22, 2026
Payout Ratio
0.00%
Updated Oct 22, 2026
Minority Interest (Equity)
53.72MCNYFY2025 · Dec 31, 2025
Revenue
4.98BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
4.99BCNYFY2025 · Dec 31, 2025
Gross Profit
-2.30MCNYFY2025 · Dec 31, 2025
Operating Income
-112.32MCNY
-16.84M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-299.04MCNYFY2025 · Dec 31, 2025
Income Tax Expense
2.10MCNYFY2025 · Dec 31, 2025
Net Income
-301.14MCNYFY2025 · Dec 31, 2025
EBIT
-176.31MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
122.53MCNYFY2025 · Dec 31, 2025
Research & Development
21.05MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
29.98MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
21.30MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
4.25MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
122.73MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.3000CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.3000CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
999.08MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
999.08MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-301.14MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
1.42MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-77.69MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-109.88MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
19.82MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-301.14MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
118.63MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
101.80MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
3.03MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-32.19MCNYFY2025 · Dec 31, 2025
Other Investing Activity
154.74MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
122.55MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
283.60MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-320.53MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-43.20MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-370.76MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-450.89MCNYFY2025 · Dec 31, 2025
Shares Outstanding
1.01BSharesUpdated Oct 22, 2026
Float Shares
675.94MSharesUpdated Oct 22, 2026
% Held by Insiders
35.27%
vs all stocks
Updated Oct 22, 2026
% Held by Institutions
0.67%
vs all stocks
Updated Oct 22, 2026
Total Cash (MRQ)
78.59MCNY
11.78M · vs all stocks (USD)
Updated Oct 22, 2026
Total Cash per Share (MRQ)
0.0780CNYUpdated Oct 22, 2026
Total Debt (MRQ)
926.05MCNY
138.81M · vs all stocks (USD)
Updated Oct 22, 2026
Total Debt to Equity (MRQ)
0.7799x
Updated Oct 22, 2026
Current Ratio (MRQ)
0.2040x
Updated Oct 22, 2026
Book Value per Share (MRQ)
1.13CNYUpdated Oct 22, 2026
Total Assets
4.14BCNY
620.25M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
329.19MCNYFY2025 · Dec 31, 2025
Total Liabilities
2.88BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
3.81BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
998.76MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
1.88BCNYFY2025 · Dec 31, 2025
Cash
19.77MCNYFY2025 · Dec 31, 2025
Cash Equivalents
44.98KCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
19.82MCNYFY2025 · Dec 31, 2025
Accounts Receivable
9.22MCNYFY2025 · Dec 31, 2025
Inventory
179.14MCNYFY2025 · Dec 31, 2025
Accounts Payable
811.94MCNYFY2025 · Dec 31, 2025
Short-term Debt
332.05MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
39.86MCNYFY2025 · Dec 31, 2025
Long-term Debt
644.01MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
196.09MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
1.01BCNYFY2025 · Dec 31, 2025
Retained Earnings
-1.64BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.26BCNY
189.08M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
2.31CNYUpdated Oct 22, 2026
52-Week High
6.90CNYUpdated Oct 22, 2026
52-Week Change
16.03%
vs all stocks
Updated Oct 22, 2026
Beta
0.4490x
vs all stocks
Updated Oct 22, 2026
50-Day MA
3.18CNYUpdated Oct 22, 2026
200-Day MA
3.27CNYUpdated Oct 22, 2026
Avg 10-Day Volume
209.56MSharesUpdated Oct 22, 2026
Avg 30-Day Volume
102.69MSharesUpdated Oct 22, 2026
Diluted EPS (TTM)
-0.2800CNYUpdated Oct 22, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
A weak, thin-volume bounce inside a decline that is still far from recovered.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 0.76: distress zoneCritical
Altman Z-Score: 0.76
Supply Chain
Upstream position: supplies 4 industries, depends on 1Notable
Outgoing: 4.00Incoming: 1.00
Scale
Revenue is $775.29M, above the global median of $566.17MNotable